High incidence and mortality of COVID-19 among patients with haematological malignancies: an observational study in santander, Colombia

Abstract

The incidence and prognosis of COVID-19 in patients with haematological malignancies (HM) are of utmost interest due to their high degree of humoral and cellular dysfunction. Previous research suggests that patients with HM experience significant morbidity and mortality resulting from COVID-19 infection compared to the general population [1,2]. A recent study on children with HM suggest they are at no greater risk of severe SARS-CoV-2 infection than those with non-HM [3]. However, there is a limited number of studies about COVID-19 in patients with HM, particularly in Latin America. Therefore, this study aims to report the real-world incidence and outcomes of COVID-19 in patients with HM compared to the general population in Santander, Colombia....